Chargement en cours...
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
INTRODUCTION: Lasmiditan is a selective serotonin (5-HT1F) receptor agonist approved in the US for the acute treatment ofmigraine in adults. This phase I, open-label, two-cohort study assessed the pharmacokinetics (PK), safety, and tolerability of lasmiditan in patients with migraine aged 6 to <...
Enregistré dans:
| Publié dans: | Clin Pharmacokinet |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8195962/ https://ncbi.nlm.nih.gov/pubmed/33565026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00966-z |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|